RecruitingNCT07061288
About this title
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Read the official source — NCT07061288What is this study about?This study evaluates the safety of KarXT for people with schizophrenia.
Multiple locations, including Los AlamitosSchizophreniaMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Bristol-Myers Squibb (Pharmaceutical company)
RecruitingNCT07621237
What is this study about?Researchers are comparing TNX-102 SL and placebo to find out how the approaches affect depression symptoms in people with depression.
Multiple locations, including PhoenixDepressionMedication studyAges 18+
- Countries
- United States
- Sponsor
- Tonix Pharmaceuticals, Inc.
RecruitingNCT07540338
What is this study about?Researchers are comparing lithium levels in the brain and blood after AL001 and immediate-release lithium carbonate, and assessing safety in adults with bipolarity type I.
In BostonBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Alzamend Neuro, Inc.
RecruitingACTRN12618001956291
Official study titleA Single-Arm, Single Sequence, Multiple Ascending Dose Study of the Safety and Tolerability of AB-2004 in a Pediatric Autism Spectrum Disorder Population
In South BrisbaneMental healthInterventional studyAges 12–17
- Countries
- Australia, New Zealand
- Sponsor
- Axial Biotherapeutics Australia Pty Ltd.
RecruitingISRCTN60701389
In United KingdomADHDResearch studyAges 6–12
- Countries
- United Kingdom
- Sponsor
- University Hospital Southampton NHS Foundation Trust
RecruitingNCT07405398
In WilmingtonAddictionDevice studyAges 22+
- Countries
- United States
- Sponsor
- OpiAID
RecruitingNCT06667674
About this title
A Swedish Internet CBT for Prolonged Grief Disorder: a Three-armed RCT
Read the official source — NCT06667674Official study titleEfficacy and Mechanisms of Change of Online Cognitive Behavioural Therapy for Prolonged Grief Disorder After Loss: a Three-armed Randomised Control Trial
In UppsalaProlonged grief disorderBehavioural studyAges 18+
- Countries
- Sweden
- Sponsor
- Uppsala University
RecruitingACTRN12623001059651
Official study titlePragmatic trial of the efficacy of a targeted digital intervention for reducing suicidal ideation in youth with suicidal thoughts and behaviours attending outpatient care
In ParkvilleSuicidality, DepressionInterventional studyAges 15–25
- Countries
- Australia
- Sponsor
- Orygen
RecruitingNCT06299189
About this title
A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
Read the official source — NCT06299189Official study titleA Therapist Guided Internet-delivered Treatment for Adults With ADHD - an Open Effectiveness Trial in Routine Care
In BergenADHDBehavioural studyAges 18+
- Countries
- Norway
- Sponsor
- Haukeland University Hospital
RecruitingISRCTN13757428
In NorwayMental healthResearch studyAges 12–80
- Countries
- Norway
- Sponsor
- Centre for Child and Adolescent Mental Health, Eastern and Southern Norway
RecruitingNCT06315114
About this title
A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders
Read the official source — NCT06315114Official study titleA Transdiagnostic Mentalization-based Intervention (LIGHTHOUSE Parenting Program) Versus Care as Usual for Parents With Mental Disorders in Adult Mental Health Service: a Randomised Clinical Trial
Multiple locations, including Gentofte MunicipalityMental healthBehavioural studyAges 18–65
- Countries
- Denmark
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
RecruitingNCT04793828
About this title
A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders
Read the official source — NCT04793828Official study titleThe Effect of a Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders
In BerlinAnxietyBehavioural studyAges 18–65
- Countries
- Germany
- Sponsor
- Charite University, Berlin, Germany